Kevin Robert Lind - 12 Aug 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CEO, Director
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Issuer symbol
LBPH
Transactions as of
12 Aug 2024
Transactions value $
$259,995
Form type
4
Filing time
13 Aug 2024, 18:03:42 UTC
Previous filing
09 Feb 2024
Next filing
29 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LBPH Common Stock Options Exercise $250,683 +80,265 +23% $3.12 428,715 12 Aug 2024 Direct
transaction LBPH Common Stock Options Exercise $9,311 +2,217 +0.52% $4.2 430,932 12 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Options Exercise $0 -80,265 -23% $0 268,185 12 Aug 2024 Common Stock 80,265 $3.12 Direct F1
transaction LBPH Stock Option (Right to Buy) Options Exercise $0 -2,217 -1.1% $0 192,783 12 Aug 2024 Common Stock 2,217 $4.2 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in 24 equal monthly installments commencing November 27, 2022.
F2 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.